Brokerages Set Apogee Therapeutics, Inc. (NASDAQ:APGE) Target Price at $92.17
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock in the […]
Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) has earned an average recommendation of “Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock in the […]